The Bill Kelly Show Podcast:
Dominic Barton, a strong advocate for increased trade with China during his term as ambassador, is stepping down amidst growing pressure from the administration of U.S. President Joe Biden for Ottawa to take a tougher stance with Beijing, foreign policy and national security experts said.
Barton, who was appointed by the Trudeau government in September 2019, announced his resignation Monday, citing his success “working to secure the release” of Canadians Michael Kovrig and Michael Spavor as the fulfillment of a priority mission handed to him by Prime Minister Justin Trudeau.
ALSO: Canada should join diplomatic boycott of Beijing Winter Olympics says O’Toole
GUEST: Dr. Lori Turnbull, Director of the School of Public Administration with Dalhousie University
-
Are the new Canadian travel restrictions clear? Do travelers know what is expected of them? Are airports concerned with the impact of Omicron during the busy travel season? We saw what happened with the land border - no one knew what to do.
ALSO: Most Canadians support strong travel restrictions amid Omicron COVID-19 variant: Poll
GUEST: Daniel-Robert Gooch, President of the Canadian Airports Council
-
The federal government will hand over thousands of previously undisclosed residential school documents to the National Centre for Truth and Reconciliation.
In an interview, Crown-Indigenous Relations Minister Marc Miller said the government has come to the conclusion that continuing to withhold the documents is a breach of Ottawa’s “moral duty” to survivors of the schools.
GUEST: Dr. Dawn Lavell-Harvard, Director at the First Peoples House of Learning at Trent University
-
Merck Canada announced on Monday that it is partnering with Thermo Fisher Scientific to manufacture its COVID-19 antiviral drug in Canada for global distribution in a deal Ottawa hopes will help jump-start the country’s position as a biomanufacturing centre and better secure its supply chain for future public health emergencies.
The existing Thermo Fisher facility in Whitby, Ont. will produce doses of molnupiravir, an investigational drug developed in collaboration with Ridgeback Biotherapeutics, for distribution in Canada, the U.K., the European Union, Asia Pacific, and Latin America, pending approvals in those respective regions. The drug is awaiting approval by Health Canada.
GUEST: Marvin Ryder, Professor with the DeGroote School of Business at McMaster University
See omnystudio.com/listener for privacy information.